Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Oilsands Quest Gets Court Approval Of C$7 Mln Sale Of Eagles Nest Asset

3/15/2012 4:06 PM ET

Oilsands Quest Inc. (BQI: Quote) said that it has received approval from the Alberta Court of Queen's Bench for the sale of the Company's non-core Eagles Nest asset to Cavalier Energy Inc., an unrelated third party, for C$7.005 million.

As previously announced, Oilsands Quest reopened the sale process for its Eagles Nest asset as FAMA Capital Ltd. defaulted on an earlier Purchase and Sale Agreement. The Company said that it signed a new Purchase and Sale Agreement with Cavalier and the transaction, subject to normal closing conditions, is expected to close on or before March 23, 2012.

Click here to receive FREE breaking news email alerts for OILSANDS QUEST INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The downturn in Eurozone's private sector economy eased sharply in May, but the improvement is unlikely to provide sufficient lift to the region's economy to avoid a further contraction in the second quarter. The Swiss National Bank on Thursday said it will retain the currency ceiling at CHF 1.2 per euro as risks to the economy from external developments remains high. The target range for the three-month Libor was also left unchanged at 0.0-0.25 percent. The decision was in line with economists' forecast. "Tensions can reappear at any moment on global financial markets," the central bank said. China's manufacturing activity contracted at a faster pace in June, reducing the prospects of a promising economic recovery, preliminary results of a survey by Markit Economics and HSBC revealed Thursday. The flash manufacturing purchasing managers' index fell to 48.3 in June from 49.2 in May. The index is now at its lowest level in nine months.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.